Overview

E. Coli Nissle in Oncology

Status:
Completed

Trial end date:
2018-01-01

Target enrollment:

Participant gender:

Summary

In patients with gastric or colorectal cancers, where a treatment with 5-Fluoruracil in combination with other chemotherapeutic remedies (FLO, FOLFOX, FOLFOX-Bev, FOLFIRI) is planned, it shall be investigated whether E. coli Nissle suspension has an effect on duration and intensity of chemotherapy induced diarrhea.

Phase:

Phase 3

Details

Lead Sponsor:

University of Hohenheim

Collaborator:

Ardeypharm GmbH